Sichenzia Ross Ference LLP

Author Archives: Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters. Visit SRF's LinkedIn page

Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $3.5 Million Public Offering for Safe-T Group Ltd.

safe-t

Press Release – New York, NY – November 5, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and warrants of Safe-T Group Ltd., a provider of Secure Access solutions for on-premise and hybrid cloud environments (NASDAQ, TASE: SFET).

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in a $1.8 Million Private Placement

document security systems logo

New York, NY – November 5, 2019 – Sichenzia Ross Ference LLP, announced today that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and consumer engagement technology, in a private placement of 6,000,000 shares of the company’s common stock at a purchase price of $0.3037 per share. DSS received gross proceeds of $1,822,200 from the offering, which was funded entirely by the company’s Chairman of the Board of Directors, Mr. Heng Fai Ambrose Chan. continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $3 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

co crystal pharma inc

Press Release – New York, NY – November 4, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,529,412 shares of Cocrystal Pharma, Inc. (NASDAQ: COCP) common stock, at a price of $0.85 per share for gross proceeds of approximately $3.0 million. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics. continue reading >>

Sichenzia Ross Ference LLP Adds Two New Partners to its Los Angeles Office

NEW YORK and LOS ANGELES, Oct. 23, 2019 (GLOBE NEWSWIRE) — Sichenzia Ross Ference LLP, a full service law firm, announced today that it has added two new partners, Ovsanna Takvoryan and Kristine Takvoryan, to its nationally recognized corporate and securities practice. Ovsanna and Kristine will operate out of the firm’s Los Angeles office, further bolstering its west coast presence. continue reading >>

Sichenzia Ross Ference LLP Ranked as a Top Issuer Counsel for 2019 Q3

srf square banner

Press Release – New York, NY – October 23, 2019 – PlacementTracker, part of the Business Intelligence Division of Informa PLC, has ranked Sichenzia Ross Ference LLP among the most active issuer counsels in the U.S. PIPE and private placement markets for the third quarter of 2019 by the number of transactions, representing issuers in over $50 million of placed securities. Read PlacementTracker’s full press release here.

Attorneys Selected for Inclusion on 2019 Super Lawyers Lists

Press Release – New York, NY – October 15, 2019 – Sichenzia Ross Ference LLP, a leading corporate and securities law firm, announced today that seven of its attorneys were recognized by Super Lawyers Magazine for 2019. Those Sichenzia Ross members include:

  • Partner A.R. John Hitchings, Partner Jay Yamamoto, Associate Owen A. Kloter, and Associate Gary Varnavides were all named New York Metro Rising Stars for 2019
  • Founding Partner Michael Ference and Partner Sameer Rastogi were recognized for their work in the Securities Litigation category
  • Founding Partner Gregory Sichenzia was recognized for his work in the Securities and Corporate Finance category

Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing

Press Release – New York, NY – October 15, 2019Sichenzia Ross Ference LLP founding partner Gregory Sichenzia will join representatives of client Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical stage, specialty pharmaceutical company, focused on treatment solutions for depression, CNS and ophthalmological disorders, at the Nasdaq MarketSite in Times Square to ring the October 18 opening bell.

Mr. Sichenzia will take the stage along with a group of Relmada Therapeutics leaders, including Chief Executive Officer Sergio Traversa, PharmD, MBA. You can tune in October 18 at 9:30am EST on Facebook Live or via the Nasdaq Webcam. 

Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting

New York, NY – October 10, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), in the Company’s up-listing to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by Gregory Sichenzia and partner Barrett DiPaolo. The up-listing is effective for trading on October 10, 2019, and RLMD’s common stock will trade under its existing stock symbol, “RLMD.”

continue reading >>

Founding Partner Marc J. Ross, Esq. Speaks at CBD Mountain Exposition in Denver, CO

Press Release – New York, NY – October 9, 2019 – Sichenzia Ross Ference LLP founding partner Marc. J. Ross Esq., will speak at the CBD Mountain Exposition on October 12, 2019 at the Colorado Convention Center in Denver, Colorado. His presentation, titled “It’s Legal, Or Is It? – A Look At The Legalities Of CBD,” will observe and dissect the law encompassing CBD to clarify and explain legal issues surrounding CBD. The presentation is part of a two day symposium from October 11-12, 2019 that brings the cannabis and CBD industry together for learning, sharing, connecting and business building.

Please visit the website here to purchase tickets or learn more.

Sichenzia Ross Ference Represents Innovative Cosmetic Concepts in Joint Venture

Press Release – New York, NY – October 4, 2019 – Sichenzia Ross Ference LLP acted as counsel for Innovative Cosmetic Concepts LLC (“ICC”) in a joint venture with an entity controlled by Rachel Levin. ICC is a global manufacturer and distributor of high quality cosmetic and personal care products. Rachel Levin is a social influencer with the fastest growing YouTube Channel in the world “RCH Beauty101” with over 14 million subscribers. The SRF team was led by partner, Arthur Marcus.

Sichenzia Ross Ference Represents Pareteum Corporation in $40 Million Offering of Common Stock and Warrants

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – September 27, 2019 – Nationally-recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: “TEUM”), global cloud software communications platform company, in an underwritten public offering of 18,852,273 Common Stock Units, each consisting of one share of TEUM’s common stock, one Series A Purchase Warrant to purchase one share of TEUM’s common stock, and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock, and 3,875,000 Pre-Funded Units, consisting of one pre-funded warrant to purchase one share of TEUM’s common stock together with one Series A Purchase Warrant to purchase one share of TEUM’s common stock and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock.

continue reading >>

Founding Partner Marc J. Ross, Esq. Quoted on New Jersey’s Review of CBD Use in Brownie Ingredients

Press Release — September 30, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Marc. J. Ross, Esq. was quoted in an NJ.com story entitled CBD is an ingredient in N.J. brownies, beers and high-end dinners. The FDA says that’s illegal. Marc describes outcomes stemming from FDA review, and is quoted on New Jersey’s ambitions for trying to get ahead of the curve and address what they think is right with its citizens.

Please read the full article here.

Founding Partner Marc J. Ross, Esq. Presents Legal Webinar on The Business and Law of Marijuana

Press Release — September 12, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Marc. J. Ross, Esq. presented a webinar course for the Clear Law Institute, titled “The Interplay Between State Laws Legalizing Recreational and/or Medical Marijuana Uses and the Federal Controlled Substance Act,” on Wednesday, September 18, 2019. The presentation, which is Continuing Legal Education (“CLE”) accredited, discussed the interplay between state and federal laws legalizing recreational and/or medical marijuana uses.

To purchase this webinar, please visit the website here and include speaker code MRoss231979 for a 35% discount.

Founding Partner Marc J. Ross, Esq. Speaks About Cannabis at NECANN New Jersey Cannabis Convention

Press Release — September 12, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Marc. J. Ross, Esq. spoke  at the New Jersey Cannabis Convention, presented by NECANN on September 15, 2019 at the A.C. Convention Center in Atlantic City. This presentation addressed the “Budding Business Opportunities” and covered a variety of issues ranging from banking, to taxes, to CBD and ethical issues. The two-day symposium will bring the cannabis industry together for learning, sharing, connecting and business building.

Learn more about the event by visiting the website.

Sichenzia Ross Ference LLP Acts as Principal Attorney Liaison for Bannerman Resources Limited on OTCQB Listing

Press Release – New York, NY – September 18, 2019 – Sichenzia Ross Ference LLP announced today that it sponsored Bannerman Resources Limited (OTCQB: “BNNLF”), an Australian uranium exploration and development company, for the OTCQB. Sichenzia Ross Ference is a qualified firm responsible for providing guidance on OTCQB requirements and recommending membership. The SRF team was led by partner Darrin Ocasio.

Litigation Associate

We are looking for a litigation associate with 2 to 3 years of general commercial litigation experience. The candidate should possess experience in Securities Litigation and FINRA Arbitration, defending claims unique to the financial services industry, including claims for suitability, churning and failure to supervise.  Excellent writing and research skills.  New York bar required.

Please send resumes to abryer@srf.law

Sichenzia Ross Ference Founding Partner Gregory Sichenzia to Moderate Cannabis Panel at the Investor Summit Microcap Conference

Press Release — September 12, 2019 — New York, NY — Sichenzia Ross Ference LLP announced today that founding partner Gregory Sichenzia will moderate the Cannabis panel discussion at the Investor Summit Microcap Conference at 12pmET on September 16th at the Essex House overlooking Central Park in New York City. To register for the event, please click here.

The panel will consist of industry thought leaders including Medicine Man Technologies, Emerald Bioscience, Hillstreet Beverage, Flowr, and Power REIT. The group will discuss the growth of the cannabis industry, recent M&A trends, U.S. regulations, and medical research.

Sichenzia Ross Ference LLP Opens Office in Los Angeles; Names Three New Partners

Press Release — September 9, 2019 — New York, NY and Los Angeles, CA — Sichenzia Ross Ference LLP (SRF), a full service law firm, announced today that it has added three new partners, Joe Tagliaferro III, Barry A. Brust, and Barrett S. DiPaolo, to its nationally recognized corporate and securities practice. With the addition of Mr. Tagliaferro and Mr. Brust, the firm has established an LA office that will concentrate in the areas of corporate, securities and litigation.

continue reading >>

Sichenzia Ross Ference LLP Announces its Gold-Level Sponsorship of the H.C. Wainwright 21st Annual Global Investment Conference

Press Release — September 6, 2019 — New York, NY —Sichenzia Ross Ference LLP is a proud Gold-Level sponsor of the H.C. Wainwright 21st Annual Global Investment Conference. The conference will be held from September 8 through September 10, 2019 at the Lotte New York Palace Hotel.

Many of our partners and clients will be attending the conference, and members of the firm will be available to meet there.

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $2.0 Million Private Placement

Press Release­­ – New York, NY – August 28, 2019 – Sichenzia Ross Ference LLP announced today that it has represented the placement agent in the initial $2.0 million closing of a private placement of common stock of a development stage artificial intelligence software company.  The issuer may raise up to an additional $3.0 million in subsequent closings.  The Sichenzia Ross Ference LLP team was led by partners Michael Ference and Avital Perlman and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – August 26, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,813,559 shares of Avinger, Inc. (NASDAQ: AVGR) common stock, at a price of $1.18 per share for gross proceeds of approximately $4.5 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $2.3 Million Public Offering of Common Stock of Sigma Labs, Inc.

sigma labs logo

Press Release – New York, NY – August 2, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 2.875 million shares Common Stock of Sigma Labs, Inc. (NASDAQ: SGLB) at a price of $.80 per share for gross proceeds of $2.3 million.  Sigma Labs is a provider of quality assurance software under the PrintRite3D brand.

continue reading >>

Sichenzia Ross Ference LLP Ranked as a Top Issuer Counsel for 2019 Q2  

Press Release – New York, NY – July 24, 2019 – PlacementTracker, part of the Business Intelligence Division of Informa PLC, has ranked Sichenzia Ross Ference LLP among the most active issuer counsels in the U.S. PIPE and private placement markets for the second quarter of 2019 by the number of transactions, representing issuers in over $50 million of placed securities.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $1.35 Million Underwritten Public Offering of ADSs of Immuron Limited

immuron logo

Press Release – New York, NY – July 23, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, as sole book runner in a $1.35 million Public Offering of the ADSs of Immuron Limited (NASDAQ “IMRN” ASX.”IMC”). The offering consisted of 339,130 ADS’s at a price of $4.00 per ADS for gross proceeds to the Company of $1.35 million. Immuron is an Australian biopharmaceutical company focused on oral immunoglobulin therapeutics. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Tara Guarneri-Ferrara.

continue reading >>

Legal Assistant- Mandarin speaking required

We are seeking a legal assistant to provide support to two partners. College degree is preferred with at least two years of experience in a corporate environment. Duties include answering phones, travel arrangements, time entries, preparing legal opinions, editing and formatting various documents, and other general office duties. Mandarin speaking is a requirement. Please send resumes to reception@srf.law.

Sichenzia Ross Ference LLP Represents RealWear, Inc. in $80 Million Financing Transactions

realwear inc logo

Press Release — July 9, 2019 — New York, NY — Sichenzia Ross Ference LLP represented RealWear, Inc., an innovative technology company whose flagship product, the HMT-1®, is the first ruggedized head-mounted, wearable, Android-class tablet computer that frees a worker’s hands for dangerous jobs, in financing transactions raising an aggregate of $80 million. The Series B financing round was led by Teradyne, Inc. (TER), a global leader in industrial automation, and included participation from other industry leaders including Qualcomm Ventures and Bose Ventures. JPMorgan Chase & Co. acted as the exclusive placement agent to RealWear, Inc. in connection with the Series B financing.

continue reading >>

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $20 Million Registered Direct Offering

vuzix

Press Release – New York, NY – July 8, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of approximately 5.48 million registered shares of common stock at a price of $3.65 per share and approximately 5.48 million common stock purchase warrants with an exercise price of $4.10 per share  for gross proceeds to Vuzix of approximately $20 million. The Special Equities Group, a division of Bradley Woods & Co. Ltd. acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Tara Guarneri-Ferrara, and Counsel Jeff Cahlon.

Sichenzia Ross Ference Founding Partner Marc Ross Interviews with CFN Media on Business and Law of Marijuana

Press Release – New York, NY – July 8, 2019 – Sichenzia Ross Ference LLP founding partner Marc Ross participated in an interview with CFN Media to discuss the ever changing landscape of the Cannabis industry. The interview took place after an informative panel discussion about the Business and Law of Marijuana at the Cannabis World Congress Business Exposition at the Jacobs Javits Convention Center in New York City. Please find the full interview here.

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $5.6 Million Underwritten Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented its client, Document Security Systems, Inc. (NYSE American: DSS), in a $5.6 million public offering of its common stock.  The offering consisted of 11.2 million shares of common stock at a price of $0.50 per share. Aegis Capital Corp. served as sole book running manager in connection with the offering. DSS is a leader in the anti-counterfeit, authentication and diversion protection technology space. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia, Darrin Ocasio, Tara Guarneri-Ferrara and Jeffrey D’Angelo.

New Jersey Bureau of Securities Proposes New Rule to Create State-Level Fiduciary Duties For Broker-Dealers, Associated Persons, Investment Advisers and Investment Adviser Representatives

On April 15, 2019, the New Jersey Bureau of Securities, within the Division of Consumer Affairs, proposed a new state-level rule requiring all registered financial services professionals to act in accordance with the fiduciary duty to their customers when providing investment advice or recommending to a customer an investment strategy, the opening of or transfer of assets of any type of account, or the purchase, sale, or exchange of any security. Under the proposed rule, any conduct falling short of this fiduciary duty would constitute a “dishonest and unethical practice.”

Under current federal standards, only investment advisers subject to the Investment Advisors Act of 1940 and their representatives operate subject to a fiduciary duty standard. Among other differences from their investment adviser counterparts, broker-dealers and their associated persons typically receive only commissions for transactions they facilitate and for selling financial products – not compensation for financial planning, discretionary trading or investment portfolio advice and management. New Jersey proposes a substantial expansion of regulatory requirements on broker-dealers and their associated persons conducting business within the State of New Jersey.

The Proposed Rule

Dishonest or Unethical Practices

The proposed regulation, N.J.A.C. 13:47A-6.3 and N.J.A.C. 13:47A-6.4, seeks to impose a uniform, state-level duty of care and loyalty for both investment advisers and their representatives as well as broker-dealers and their associated persons doing business within the State. The State’s proposal is a product of its dissatisfaction with the pace of meaningful change to the federal regulatory framework following the United States Department of Labor’s failed Fiduciary Rule* and the scope of the United States Securities and Exchange Commission’s proposed Regulation Best Interest**, to promulgate a new, uniform federal interest ahead of the customer’s interest; (ii) act with diligence, care, skill and prudence; and (iii) disclose and mitigate, or eliminate, material conflicts of interest arising from financial incentives associated with the recommendation. Regulation Best Interest does not apply a fiduciary standard to broker-dealers or its associated persons. In addition, Regulation Best Interest allows some duty of loyalty conflict of interests to be mitigated through disclosure to the customer.

Expanded Reach and Duration

As proposed, the fiduciary duty would apply to recommendations to purchase, sell or hold securities and to recommendations about investment strategy, the opening of an account or the transfer of assets to any type of account. Further, the new duty would also apply to contractual and discretionary fiduciaries in addition to investment advice fiduciaries. Moreover, if investment advice is provided, the new fiduciary duty rule would impose an ongoing fiduciary duty for the entire relationship. In other words, dual registered persons who provide both brokerage recommendations and investment advice to a retail customer would be subject to the fiduciary duty for the life of the relationship***

Creating New and Rejecting Old Presumptions

The proposed rule also creates a new presumption that the investment adviser, its representative, the broker-dealer or its associated person breaches the duty of loyalty for any recommendation concerning the opening of, or transfer of assets to a specific type of account, or the purchase, sale or exchange of a specific security “that is not the best of the reasonably available options.” According to the State, the payment of transaction-based fees to broker- dealers or associated persons will not itself be deemed a breach of fiduciary duty, however, so long as “the fee is reasonable and is the best of the reasonably available fee options and the duty of care is satisfied.”

The regulation, if adopted in current form, disallows a presumption that disclosing a conflict of interest satisfies the duty of loyalty.

The proposed regulation applies to retail customer only, i.e., not banks, savings and loan associations, insurance companies, investment advisers, broker-dealers, fiduciaries to employee benefit plans, its participants or beneficiaries, or individuals with at least $50 million in assets.

Books and Records Requirements

Ostensibly to avoid federal preemption, the State’s proposal does not require any new or additional capital, custody, margin, financial responsibility, making and keeping of records, bonding or financial or operational reporting requirements on broker-dealers beyond those already required by federal law.

**********

If you have any questions about the issues addressed in this Broker-Dealer Regulation Alert, if you would like a copy of any of the materials mentioned in it or if you would like to continue to receive Broker-Dealer Regulation Alerts, please do not hesitate to call or email Securities and Commercial Litigation and Securities Regulatory Practice Partner Daniel Scott Furst at (646) 810-2185 or sfurst@srf.law ****

*The Department of Labor’s rule was to be implemented starting April 10, 2017, however, on or about June 21, 2018, the United States Fifth Circuit Court of Appeals vacated the rule, effectively killing it.

***Broker-dealer associated persons who act in a broker-only capacity, however, would be subject to the fiduciary duty only through the transaction’s execution.

**The final rulemaking of Regulation Best Interest was approved in a 3-to-1 vote by the Commission on June 5, 2019. Regulation Best Interest is effective 60 days after publication in the Federal Register, and the anticipated implementation date is June 30, 2020. Regulation Best Interest would create a national, heightened standard of conduct for broker-dealers. Regulation Best Interest provides that when a broker- dealer or its associated person recommends securities transaction or investment strategy, the broker-deal or associated person must: (i) act in the customer’s best interest, without placing its financial or other standard applicable to investment advisers and broker-dealers. Specifically, the proposed regulation would define a “dishonest or unethical practice” to include: recommending to a customer, an investment strategy, the opening of, or transfer of any assets to, any type of account, or the purchase, sale, or exchange of any security or securities without reasonable grounds to believe that such strategy, transaction, or recommendation is suitable for the customer based upon reasonable inquiry concerning the customer’s investment objectives, financial situation, and needs, and any other relevant information known by the broker-dealer[.]

****This Broker-Dealer Regulation Alert is for general information purposes only of interest to New Jersey broker-dealers and is not intended to advertise our services, solicit clients or represent our legal advice.

Sichenzia Ross Ference LLP Represents Medicine Man Technologies, Inc. in Private Placement Offering of up to $14 Million

medicine man technologies

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Medicine Man Technologies, Inc. (OTC: MDCL) (“Medicine Man or the “Company”) in a securities purchase agreement with Dye Capital & Co. for the sale of up to $14 million of shares and common stock purchase warrants of the Company. The shares were sold at a price of $2.00 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $3.0 Million Registered Direct Offering of Common Stock and Warrants of General Cannabis Corp.

Press Release­­ – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that it has represented a FINRA member firm as financial advisor in the registered direct offering of 3.0 million shares of common stock and 3.0 million warrants of General Cannabis Corp. (OTCQX: CANN) at a price of $1.00 per share for gross proceeds of approximately $3.0 million.

continue reading >>

Sichenzia Ross Ference LLP Represents AIT Therapeutics in $8 Million Private Placement

AIT therapeutics

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.0 Million Public Offering of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP (SRF) announced today that it has represented Aegis Capital Corp. as sole book-running manager in the underwritten public offering of 1.66 million shares Common Stock of Medalist Diversified REIT, Inc.(NASDAQ: MDRR) at a price of $4.80 per share for gross proceeds of $8.0 million.

continue reading >>

Sichenzia Ross Ference LLP Announces $1.3 million Private Placement of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as placement agent in a private offering of 270,833 shares of Common Stock of Medalist Diversified REIT, Inc. (NASDAQ: MDRR) at a purchase price of $4.80 per share for gross proceeds of approximately $1.3 million.

continue reading >>

Sichenzia Ross Ference Litigation Partners Marc Ross and Scott Furst Prevail on Multiple Appeals on Behalf of Client in a Multi-Year Southampton Property Dispute

Press Release – New York, NY – May 30, 2019 – Sichenzia Ross Ference LLP (SRF) litigation partners Marc Ross and Scott Furst, together with appellate counsel, prevailed on multiple appeals taken to the Supreme Court New York, Appellate Division: Second Judicial Department.  The appeals sought to reverse a Suffolk County trial court’s denial of a motion to dismiss a lawsuit commenced in 2015 by adjacent property owners who sought and were awarded by the trial court injunctive relief halting an ongoing, residential construction overlooking Shinnecock Bay, in the Town of Southampton.  An earlier, related litigation concerning the property and its compliance with the local zoning laws relating to height and setback requirements, ultimately failed to resolve the dispute and gave rise to the instant lawsuit at which time SRF was engaged by the Appellant to take over the litigation.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $2.0 Million Underwritten Public Offering of ADSs of Immuron Limited.

immuron logo

Press Release – New York, NY – May 29, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, Inc. as sole book runner in a $2.0 million Public Offering of American Depositary Shares (ADSs) of Immuron Limited (ASX: “IMC”; NASDAQ “IMRN”).

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) in Offering of $1.2 Million American Depositary Shares

genetic technologies logo

Press Release – New York, NY – May 23, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE), a diversified molecular diagnostics company, in a registered direct offering of American Depositary Shares (“ADSs”) and warrants to purchase ADSs.  The Company received gross proceeds of approximately $1,200,000.

continue reading >>

Founding Partner Marc Ross Publishes Op-Ed on Business and Legality of CBD

New York, NY – May 10, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that founding partner Marc Ross published an opinion piece on the business and legality of CBD. The piece, titled “Sorting Out the Confusion Regarding CBD,” was featured on Aeroflow Naturals’ education blog, a resource center for all things CBD.

Aeroflow Naturals is a leading provider of CBD and a subsidiary of Aeroflow Healthcare, a premier provider of durable medical equipment (DME) and services in the Southeastern United States.
You can read the full article here.

Sichenzia Ross Ference LLP Congratulates AIT Therapeutics, Inc. on NASDAQ Uplisting

New York, NY – May 9, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented AIT Therapeutics, Inc. (NASDAQ: AITB), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Gregory Sichenzia and partner Avital Perlman. The uplisting is effective for trading on May 7, 2019, and AITB’s common stock will trade under its existing stock symbol, “AITB.”

continue reading >>

Litigation Partner Scott Furst Successfully Defeats Appeal In $10,000,000 Insurance Dispute

Press Release – New York, NY – May 9, 2019 – Sichenzia Ross Ference LLP (SRF) litigation partner Scott Furst successfully defeated an appeal taken to the Supreme Court New York, Appellate Division: Second Judicial Department, which sought to vacate a trial court’s complete dismissal of a multi-party, multi-claim lawsuit for damages and to rescind and restore approximately ten million dollars of insurance coverage ($10,000,000.00).  Plaintiffs brought claims that included fraud, breach of contract and violations of the New York State Insurance Law against an insurance agent, insurance agency and insurer.  Plaintiffs commenced their lawsuit in July 2014 and, during almost five years of litigation, Mr. Furst, on behalf of the agent and agency, successfully moved to dismiss the original complaint, defeated a motion to renew and reargue and moved to dismiss the amended complaint from which the appeal was taken.  The Second Department denied the appeal on multiple grounds giving particular emphasis to the Defendants’ evidence that contradicted the Plaintiffs’ allegations.  The Court also concluded that Plaintiffs could not, as a matter of law, state claims against the agent or agency.  Relying on the facts and law presented by SRF, the Second Department also affirmed the trial court granting summary judgment in favor of the insurer and against the Plaintiffs, which was also appealed.

Odierna v. RSK, LLC, 2019 N.Y. App. Div. LEXIS 2573 (2d Dep’t 2019).

Sichenzia Ross Ference LLP Celebrates its 21st Anniversary

Press Release – New York, NY – May 7, 2019 –  Originally founded on May 5, 1998, Sichenzia Ross Ference LLP celebrates its 21st year of legal excellence and service for its diverse range of clientele.  From its original three founding attorneys SRF has grown to a family of 65 people who remain dedicated to the highest level of legal counsel spanning a number of industries, including but not limited to securities, corporate, real estate, cannabis, trust & estates, litigation and several others.

Founding Partner Marc Ross Participates in Panel Discussion on Legal Cannabis

Press Release – New York, NY – April 25, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, today announced that founding partner Marc Ross participated in a panel discussion on the future of the legal cannabis industry. The discussion was featured in a recent episode of “Innovators with Jane King,” an interview series hosted by Nasdaq.

A video of the full discussion can be found here: https://www.youtube.com/watch?v=OUtVZfF-_b0

Founding Partner Gregory Sichenzia Quoted in Article on How to Determine if Your Company is IPO Ready

Press Release – New York, NY – April 24, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, shared today that founding partner Gregory Sichenzia was recently featured in an article on YouInc, an online resource for entrepreneurs and business owners.

Greg spoke with reporter Jordan Rosenfield to share insights on when companies should consider an initial public offering (IPO).

Sichenzia Ross Ference Closes $180 Million Real Estate Portfolio Acquisition on Behalf of Client

Press Release – New York, NY – April 22, 2019Sichenzia Ross Ference LLP, a leading corporate securities and full service law firm, today announced that it recently closed on an approximately $180 million multifamily real estate portfolio acquisition for one of its clients, a dynamic and growing real estate investment firm.  This complex transaction involved the acquisition of several REIT entities, negotiation of a preferred equity JV component and a multi-million-dollar debt facility on the portfolio of assets.  The Sichenzia Ross Ference LLP team was led by Real Estate partner Anthony Ficara, partner Mendy Piekarski and counsel Michael Wickersham.

continue reading >>

Sichenzia Ross Ference LLP Represents Quest Solutions, Inc. in $5 Million Private Placement

quest solution

Press Release – New York, NY – April 9, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Quest Solution, Inc.  (OTCQB: QUES) in the private placement of 16,666,667 unregistered shares of its common stock, at a purchase price of $.30 per share, for gross proceeds of approximately $5,000,000. Investors also received warrants to purchase 16,666,667 shares of common stock at an exercise price of $.35 per share.

continue reading >>

Sichenzia Ross Ference LLP Congratulates INmune Bio Inc., on Initial Public Offering

New York, NY – April 9, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented INmune Bio Inc. (NASDAQ: INMB), in the Company’s Initial Public Offering and subsequent listing on the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Marc Ross and partners David Manno and Thomas Rose. The stock became effective for trading on February 4, 2019, and its common stock trades under the symbol, “INMB.”

Follow Sichenzia Ross Ference on Twitter: @SichenziaRoss

 

 

Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $25 Million Credit Facility with East West Bank

new age beverage corp. logo

Press Release – New York, NY – April 2, 2019 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in a loan and security agreement with East West Bank which provides for up to $25 million aggregate principal amount revolving credit facility, which includes a $15 million term loan and a feature to provide an additional $10 million should the company choose to utilize it and a $10 million revolving line of credit.

continue reading >>

Sichenzia Ross Ference LLP Announces its Platinum-Level Sponsorship of the 2019 ThinkEquity Conference

Press Release – New York, NY – March 29, 2019 – Sichenzia Ross Ference LLP is happy to announce its Platinum-Level sponsorship for the 2019 ThinkEquity Conference. The conference will be held on May 2, 2019 at The Mandarin Oriental Hotel in New York, NY.

Gregory Sichenzia, one of SRF’s founding partners, commented, “We have long been friends of ThinkEquity and are excited to support its growing conference series.”

Sichenzia Ross Ference LLP Represents LiveWell Canada Inc. in $15 Million Private Placements to Scale its CBD Operations

live well

Press Release – New York, NY – March 28, 2019 – Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that it represented LiveWell Canada Inc. (“LiveWell”), a Canadian CBD company listed on the Canadian Stock Exchange entering the U.S. markets, in a private placement offering of senior secured convertible notes with institutional investors for total aggregate gross proceeds of $15 million, which includes LiveWell’s previously closed $3 million bridge financing.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $5.4 Million Public Offering of Common Stock of Opgen, Inc.

opgen logo

Press Release – New York, NY – March 28, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 9 million shares Common Stock of Opgen, Inc. (NASDAQ: OPGN) at a price of $.60 per share for gross proceeds of $5.4 million.  Opgen is a precision medicine company harnessing the power of molecular diagnostics to combat infectious disease. The Sichenzia Ross Ference LLP team was led by partners Tom Rose, Gregory Sichenzia and Jay Yamamoto.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page
Sichenzia Ross Ference LLP

Sichenzia Ross Ference Represents Pareteum Corporation in $50 Million Credit Facility with Post Road Group

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – March 20, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a global cloud software communications platform company, as it closed a $50,000,000 committed senior secured credit facility with Post Road Group. Under the terms of the credit facility, Post Road provided Pareteum an initial loan of $25,000,000 on February 26, 2019, with additional loans in increments of $5,000,000 to be made as requested by Pareteum before the 18-month anniversary of the initial funding date.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associates Grant Levine and Huan Lou.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page
Sichenzia Ross Ference LLP

Founding Partner Marc Ross to Present Legal Webinar on The Conflicting State and Federal Laws Concerning Marijuana, Hemp and CBD

Press Release – New York, NY – March 11, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that its founding partner Marc J. Ross will present a webinar course at the Clear Law Institute, “The Interplay Between State Laws Legalizing Recreational and/or Medical Marijuana Uses and the Federal Controlled Substance Act,” on Monday, March 11, 2019 at 3:00 pm.

continue reading >>

Will The Murky Marijuana Banking Picture Finally Get Clearer?

Federal Reserve Chairman Jerome Powell, while testifying before Congress yesterday, Tuesday, February 26, 2019, explicitly acknowledged the uncertainty and tension surrounding the access of a company engaged in marijuana or marijuana-related business to banking because of conflicting state and federal laws.  When asked about the topic, the Chairman said, “I think it would be great to have clarity,” adding, “Financial institutions and their regulators and supervisors are in a difficult position with marijuana being illegal under federal law and legal under some state laws.”

Further, last week, the House Financial Services Committee made history by holding its first ever hearing on marijuana and financial services. Up for discussion at that hearing was a new draft of the Secure and Fair Enforcement (SAFE) Banking Act.  Last year, Congress introduced the SAFE Act of 2017, which stalled and went nowhere.  Colorado Rep. Ed Perlmutter, a prime sponsor of the bill, has been introducing a version of this bill for almost six years, but has failed to get a hearing until now. This year, not only is the bill going to be discussed, but the bill is even more robust, specifically adding protections for ancillary businesses providing products and services to marijuana-related businesses.

As Treasury Secretary Steven Mnuchin made clear while testifying before Congress last year, he too would like to see marijuana businesses able to access banking services.  “I assure you that we don’t want bags of cash,” he said before a House Committee last year.  “We want to find a solution to make sure that the businesses that have large access to cash have a way to get them into a depository institution for it to be safe.”

Today, while 10 states and the district of Columbia have legalized recreational marijuana, marijuana remains illegal on the federal level, listed as a Schedule 1 drug, along with heroin and LSD.  And, while an increasing number of financial institutions are willing to bank marijuana and marijuana-related businesses, there still is a predominant, industry-wide reluctance to get involved, whether because of the added compliance that is required, or because of the unclear restrictions that are promulgated, by the Department of the Treasury.

Marc J. Ross, Esq.

Marc J. Ross is a founding partner representing clients (public and private companies, brokerage firms, registered representatives, high net-worth individuals, and hedge funds) throughout the United States, North America, Asia, Europe and Israel. Mr. Ross advises clients on securities, corporate, regulatory and litigation/arbitration matters.
Marc J. Ross, Esq.

Latest posts by Marc J. Ross, Esq. (see all)

    Sichenzia Ross Ference Represents Pareteum Corporation in Tender Offer for Shares of iPass, Inc. and Completes Acquisition

    The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

    Press Release – New York, NY – February 14, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a cloud software platform, as it accepted for exchange shares  of iPass, Inc. (Nasdaq: IPAS), a provider of global mobile connectivity.

    continue reading >>

    Sichenzia Ross Ference Partner Ralph Preite Participates on Financial Poise’s “Legal Ethics – Best Practices Regarding Technology” Webinar

    Press Release – New York, NY – February 14, 2019 –  Sichenzia Ross Ference LLP Partner Ralph Preite participated on Financial Poise’s “Legal Ethics – Best Practices Regarding Technology” webinar, hosted on February 13th.

    This webinar series examines ethical issues confronted by businesses in a variety of contexts, from so called “grey areas” to those involving outright corruption. The panelists consider and recommend different approaches to ethical decision-making and the lawyer’s role in advising business clients.

    To learn more, please click here.

    Sichenzia Ross Ference LLP Adds Jeff D’Angelo as Corporate & Securities Partner

    NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) — Sichenzia Ross Ference, a leading securities and corporate law firm, announced today that Jeff D’Angelo will join the firm as a Partner in the firm’s Corporate and Securities practice, effective on February 19, 2019.

    Prior to joining SRF, Mr. D’Angelo worked with publicly-traded company Document Security Systems, Inc. in a variety of roles, including Vice-President and General Counsel. Prior to joining DSS, Mr. D’Angelo practiced corporate law for several years, and also served as Managing Director at Prudential Financial, heading its Western New York financial operation and overseeing more than 60 sales associates and managers.

    Mr. D’Angelo will represent SRF’s clients in securities law, corporate governance, commercial contracts, general corporate law, mergers & acquisitions, IPOs, technology licensing and corporate finance matters. In 2018, during his tenure as in-house general counsel for DSS, Mr. D’Angelo was nominated for the Western New York Daily Record and Rochester Business Journal’s Corporate Counsel of the Year Award.

    “Sichenzia Ross offers me the perfect transition from my role as in-house general counsel while providing an ideal platform for me to continue representing DSS as outside counsel under the SRF umbrella. I have known Greg Sichenzia for years, as we attended law school together and have collaborated professionally in the past, and I am excited to join a nationally-recognized corporate and securities law firm with such a diverse roster of innovative public company clients,” said Mr. D’Angelo. “I am confident that my experience coupled with Sichenzia Ross’ reputation for excellence will help me to continue to grow the firm’s national corporate practice.”

    Founding partner Gregory Sichenzia welcomed the addition, saying, “We are very glad to have Jeff on board. We worked with him when he was DSS’ general counsel and know that he has the professionalism and character that we seek to attract.”

    Mr. D’Angelo holds a B.S. in General Management from Purdue University, and a law degree from the Benjamin N. Cardozo School of Law.

    About Sichenzia Ross Ference LLP

    Sichenzia Ross Ference LLP

    Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

    Visit SRF's LinkedIn page
    Sichenzia Ross Ference LLP

    Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $6.5 Million Public Offering for Cellect Biotechnology Ltd.

    cellect logo

    Press Release – New York, NY – February 12, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and Warrants of Cellect Biotechnology Ltd., an Israeli biotech company (NASDAQ: APOP). National Securities Corporation and Dawson James Securities, Inc. acted as co-managers for the offering.

    continue reading >>

    Sichenzia Ross Ference LLP Congratulates Zynex, Inc., on NASDAQ Uplisting

    New York, NY – February 8, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented Zynex, Inc. (NASDAQ: ZYXI), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Gregory Sichenzia and partner Tara Guarneri-Ferrara. The up-listing is effective for trading on February 12, 2019, and ZYXI’s common stock will trade under its existing stock symbol, “ZYXI.”

    “We applaud ZYXI on the achievement of this important milestone, one that positions the Company’s to capitalize on its market objectives while it continues to develop its pain management and rehab electrotherapy devices,” said Gregory Sichenzia,  partner of Sichenzia Ross Ference LLP.

    Sichenzia Ross Ference LLP Represents INmune Bio Inc. in an $8 Million Initial Public Offering and Listing on the Nasdaq Capital Market

    inmune logo

    Press Release – New York, NY – February 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented INmune Bio Inc. (INMB), an immunotherapy company focused on developing therapies that harness the patient’s innate immune system to fight disease, in an initial public offering at a price of $8.00 per share resulting in gross proceeds of approximately $8,000,000 and listing on the Nasdaq Capital Market under the ticker symbol INMB.

    continue reading >>

    Sichenzia Ross Ference LLP Launches Cannabis Law Group

    Press Release – New York, NY – January 24, 2019 – Sichenzia Ross Ference LLP (“SRF”), a leading corporate securities and full service law firm, today announced that the firm has launched a specialty practice group devoted to servicing the legal needs of cannabis related businesses. SRF’s Cannabis Law Group is led by founding partner Marc J. Ross. The full release can also be found here.

    continue reading >>

    Sichenzia Ross Ference LLP Launches Merchant Cash Advance Practice Group

    NEW YORK, Jan. 15, 2019 — Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, today announced that the firm has launched a specialty practice group devoted to servicing the legal needs of alternative commercial financing and merchant cash advance (MCA) companies.

    Led by Sichenzia Ross Ference partner Mendy Piekarski, this multi-discipline group has established expertise in all aspects of the MCA business cycle, including capital formation, asset deployment, brokering arraignments, syndication and participation agreements, regulatory compliance, and litigation. continue reading >>

    Founding Partner Gregory Sichenzia Quoted in Leading Law Trade Publications

    Press Release – New York, NY – January 14, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, shared today that founding partner Gregory Sichenzia was featured in two leading law publications, Law.com and Law.360.

    In the Law.com article, Greg spoke with reporter Christine Simmons to share his insight on how the government shutdown may impact public companies and their legal counsel.

    In the Law360 article (subscription required), Greg spoke with Tom Zanki to discuss takeaways from the JP Morgan Healthcare conference in San Francisco.

    Sichenzia Ross Ference LLP Represents Boulder Botanicals & Biosciences Laboratories, Inc. in a $5.0 Million Private Placement

    boulder botanicals

    Press Release – New York, NY – January 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented Boulder Botanicals & Biosciences Laboratories, Inc.  (BBBL), a holding company which owns and operates several companies operating within the CBD production, extraction and distribution industries in a private placement of shares of common stock at a price of $1.00 per share resulting in gross proceeds of approximately $5,000,000.

    continue reading >>

    Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to China SXT Pharmaceuticals, Inc.’s $10.2 Million U.S. Initial Public Offering

    china sxt pharmaceuticals

    Press Release – New York, NY – January 4, 2019 – Sichenzia Ross Ference LLP congratulates China SXT Pharmaceuticals, Inc. (the “Company”) (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (“TCMPs”), on the final closing of its initial public offering on January 3, 2019. Together with the first closing on December 31, 2018, the Company raised approximately $10.2 million in gross proceeds, before deducting underwriting discounts, commissions and other offering expenses, by issuing 2,546,275 ordinary shares at a public offering price of $4.00 per share. The shares are scheduled to commence trading on the NASDAQ Capital Market today at around 2:05 p.m. ET under the ticker symbol “SXTC.”

    continue reading >>

    Sichenzia Ross Ference LLP Represents New Age Beverages Corporation in the $85 Million Acquisition of Morinda Holdings, Inc.

    new age beverage corp. logo

    NEW YORK, Jan. 03, 2019 — Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that its mergers and acquisitions team represented New Age Beverages Corporation (NASDAQ:NBEV) in its acquisition of Morinda Holdings, Inc., a Utah-based healthy beverages and lifestyle company with operations in more than 60 countries worldwide.

    The consideration for the merger was $85 million, comprised of $75 million in cash and $10 million paid in 2,016,480 shares of New Age common stock based on the 40-day volume-weighted average price calculated through December 20, 2018. The transaction was subject to the pre-merger notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended and closed on December 21, 2018.

    The full Sichenzia Ross release can be found here.

    continue reading >>

    Client Alert UPDATE: President Trump Signs 2018 Farm Bill Into Law

    Dear Clients and Friends,

    Just one week after the 2018 Farm Bill decidedly pass through the U.S. Senate and House of Representatives, President Trump signed the landmark bill into law today, December 20, 2018. The overhauled Farm Bill is the first piece of federal legislation which unambiguously removes specific permutations of hemp-derived cannabis containing tetrahydrocannabinol, or THC the active ingredient that causes the psychoactive effect of marijuana, from the Controlled Substances Act and moreover, expressly prohibits states from interfering with interstate sale and transport of such products

    Sichenzia Ross Ference LLP Represents Client in $49.3 Million Multifamily Real Estate Portfolio Acquisition

    New York, Dec. 18, 2018 – Sichenzia Ross Ference LLP (www.srf.law), a leading corporate securities and full service law firm, today announced that it closed on a $49.3 million multifamily real estate portfolio acquisition for its client, a dynamic and growing real estate investment firm.  The transaction included the assumption of a $35 million debt facility on the portfolio of assets.  The Sichenzia Ross Ference LLP team was led by Real Estate partner Anthony Ficara, partner Mendy Piekarski and counsel Michael Wickersham.

    continue reading >>

    Client Alert: U.S. Senate and House of Representatives Approve 2018 Farm Bill

    The long-awaited resurgence of the Agriculture Improvement Act of 2018, colloquially referred to as the 2018 Farm Bill, became more promising yesterday as its latest iteration received overwhelming bipartisan approval as it decidedly passed through the Senate on Tuesday, by a vote of 87-to-13, and easily passed through the House of Representatives, by a vote of 369-to-47. Now, the reality of the 2018 Farm Bill awaits the hand of President Donald Trump, who is expected to sign it into law before the end of the month.

    Most notable, the 2018 Farm Bill is set to legalize hemp, a plant that’s nearly identical to marijuana and is a key source of the highly popular health and wellness ingredient cannabinoid, or CBD. If signed into law, the 803-page Bill would be the most significant change to the Controlled Substances Act (the “CSA”) since 1971, which is illustrative of the federal government’s recognition that outdated federal regulations do not sufficiently distinguish between hemp, including CBD derived from hemp, and CBD derived from marijuana.

    In contrast to its predecessor, the voluminous 2018 Farm Bill expressly and unambiguously provides that the definition of “marihuana” under the CSA would be amended to exclude “hemp”, which, in turn, is defined as “the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.” Succinctly, if signed into law, the 2018 Farm Bill would be the first piece of federal legislation that explicitly carves out certain permutations of CBD containing tetrahydrocannabinol (“THC”), the active ingredient that causes the psychoactive effect of marijuana, from the CSA.

    Against this backdrop, financial institutions that have been reluctant to establish relationships with hemp-related business because of the inclusion of “hemp” in the CSA’s definition of “marihuana” and the February 14, 2014 guidance from the Department of the Treasury Financial Crimes Enforcement Network, may now turn a new leaf and embrace the estimated $1 billion industry.

    Relatedly, and in furtherance of the federal government’s progressive initiative toward the proliferation of the rapidly increasing hemp market, the 2018 Farm Bill also places far-reaching limitations on the States’ abilities to prevent the transport of hemp across interstate commerce. Specifically, the 2018 Farm Bill states, in relevant part, that “No State or Indian Tribe shall prohibit the transportation or shipment of hemp or hemp products,” so long as such hemp or hemp products are produced in accordance with discrete guidelines set forth elsewhere in the 2018 Farm Bill.

    Notwithstanding, this monumental shift in cannabis reform should not be misconstrued as a blanket legalization of hemp at the state level. Conversely, the 2018 Farm Bill provides a roadmap for states and Indian tribes to become the “primary regulators” of hemp production by submitting “a plan under which the State or Indian tribe monitors and regulates” the production of hemp within its borders. In this regard, those interested in getting involved in the hemp industry, in any capacity, are cautioned to review the applicable state law, which may carry more stringent restrictions than the 2018 Farm Bill, as well as any other pertinent federal authority.

    Finally, it is worth noting that nothing in the 2018 Farm Bill implicates the status quo of marijuana or CBD derived from marijuana, both of which remain illegal under federal law. And while the legal landscape remains somewhat hazy, bipartisan agreement of the 2018 Farm Bill marks a long-overdue, massive step forward for the U.S. hemp industry.

    About the authors

    S. Ashley Jaber

    S. Ashley Jaber is an associate in the firm’s Corporate and Securities practice group. Ms. Jaber represents both public and privately-held clients in a broad range of corporate and securities matters. She also assists clients in the filing of registration statements and in complying with their ongoing SEC reporting obligations.
    S. Ashley Jaber

    Latest posts by S. Ashley Jaber (see all)

      Robert Volynsky

      Robert Volynsky is an associate in the firm’s Litigation Department. Mr. Volynsky engages in securities and general commercial litigation in both state and federal courts and before regulatory agencies, including the Securities and Exchange Commission and the Financial Industry Regulatory Authority.
      Robert Volynsky

      Latest posts by Robert Volynsky (see all)

        QPAGOS Retains Sichenzia Ross Ference as SEC Counsel

        Mexico City, Dec. 03, 2018  – QPAGOS (QPAG), a leading provider of electronic payments solutions, today announced that it retained Sichenzia Ross Ference LLP (www.srf.law) to represent QPAG on general securities matters.

        Sichenzia Ross Ference LLP is a top-ranked securities law firm, just recognized for the third consecutive year on U.S. News and World Report’s “Best Law Firm” List. Its attorneys specialize in advising clients in private placements, initial (IPOs) and secondary public offerings, mergers and acquisitions (M&A), preparing SEC filings and listing to major stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets.

        Read the full release about Sichenzia Ross Ference and QPAGOs, here.

         

        Sichenzia Ross Ference LLP Represents A.G.P/Alliance Global Partners in $10 Million Public Offering for Creative Realities, Inc.

        creative realities logo

        Press Release – New York, NY – November 19, 2018 –  Sichenzia Ross Ference LLP announced today that it has represented A.G.P/ Alliance Global Partners  (through Euro Pacific Capital) as sole book running manager in the underwritten public offering of shares of Common Stock and Warrants of Creative Realities, Inc. (NASDAQ: CREX).

        continue reading >>

        Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $52 Million Underwritten Public Offering

        new age beverage corp. logo

        Press Release – New York, NY – November 14, 2018 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in an underwritten public offering of 14,835,000 shares of its common stock, which includes a full simultaneous exercise of the underwriters 15% over allotment option, at a public offering price of $3.50 per share for gross proceeds to NBEV of $51,922,500. Roth Capital Partners and A.G.P/ Alliance Global Partners acted as joint book-running managers for the offering. Please click here to read the full Sichenzia Ross release.

        continue reading >>

        Sichenzia Ross Ference LLP Ranked by U.S. News for its “Best Lawyers List” for 2019

        Press Release – New York, NY – November 13, 2018 –Sichenzia Ross Ference LLP is proud to be included in the 2019 list of “Best Law Firms” ranking issued by U.S. News & World Report. The firm was recognized as a Metropolitan “Best Law Firm” in the Corporate Law practice area. Based on a rigorous evaluation process, “Best Law Firm” is a prestigious list in which the firm is honored to be recognized.

        Sichenzia Ross Ference Represents Pareteum Corporation in Definitive Agreement to Acquire iPass, Inc.

        The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

        Press Release – New York, NY – November 13, 2018 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a cloud software platform, as it entered into a definitive agreement under which it will acquire iPass, Inc. (Nasdaq: IPAS), a provider of global mobile connectivity, in an all-stock transaction. Pareteum anticipates achieving more than $15 million in annual cost synergies; more than $12 million of such synergies are expected to be realized in the first year.

        continue reading >>

        Sichenzia Ross Ference LLP Represents Novume Solutions, Inc. in $3.3 Million Underwritten Public Offering of Common Stock

        novume logo

        Press Release – New York, NY – November 1, 2018 – Sichenzia Ross Ference LLP announced today that it has represented Novume Solutions, Inc. (NASDAQ “NVMM”) in a public offering of 4.125 million shares of its common stock at a price of $.80 per share for gross proceeds to the Company of $3.3 million.
        continue reading >>

        Sichenzia Ross Ference LLP Represents Wize Pharma, Inc. in a $4.45 Million Private Placement

        wize pharma

        New York, NY – October 24, 2018 – Sichenzia Ross Ference LLP, announced today that it represented Wize Pharma, Inc. (OTCQB: “WIZP”), a clinical stage Israel based U.S. public company focused on the treatment of ophthalmic disorders company, in a private placement with institutional and accredited investors  of 3,100,000 shares of common stock at $1.00 per share and 1,350 shares of newly created Series A preferred stock which is convertible at $1.00 per share.

        continue reading >>

        Sichenzia Ross Ference LLP Acts as General Counsel in Rusoro Mining Limited’s $1.28 Billion Settlement with Venezuela

        Press Release – New York, NY – October 15, 2018 – Sichenzia Ross Ference LLP announced today that it acted as general counsel for Rusoro Mining Limited (TSX-V: “RML”) in its $1.28 billion settlement with Venezuela after the government’s 2011 expropriation of Rusoro’s gold mining properties in the country.

        continue reading >>

        Sichenzia Ross Ference LLP Represents Rodman & Renshaw a Unit of H.C Wainwright in a $15 Million Upsized Public Offering of Medical Transcript Billing, Corp.

        mtbc.com logo

        Press Release – New York, NY – October 15,  2018 – Sichenzia Ross Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

        continue reading >>

        1 2 3 10